Cree Inc (CREE)

79.12  -1.61 (-1.99%)

After market: 79.78 +0.66 (+0.83%)

Fundamental Rating

3

CREE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. CREE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CREE is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

CREE had negative earnings in the past year.
CREE had negative earnings in each of the past 5 years.
CREE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -15.2%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -59.72%
PM (TTM) -99.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

CREE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CREE has an Altman-Z score of 3.69. This indicates that CREE is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for CREE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 3.29 indicates that CREE has no problem at all paying its short term obligations.
A Quick Ratio of 2.92 indicates that CREE has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.92

4

3. Growth

3.1 Past

CREE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.56%.
CREE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.85%.
Measured over the past years, CREE shows a very negative growth in Revenue. The Revenue has been decreasing by -20.13% on average per year.
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-27.78%
Revenue 1Y (TTM)-41.85%
Revenue growth 3Y-17.17%
Revenue growth 5Y-20.13%
Revenue growth Q2Q-78.27%

3.2 Future

The Earnings Per Share is expected to grow by 70.46% on average over the next years. This is a very strong growth
CREE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 37.07% yearly.
EPS Next Y-2.7%
EPS Next 2Y44.34%
EPS Next 3Y59.04%
EPS Next 5Y70.46%
Revenue Next Year6.86%
Revenue Next 2Y26.16%
Revenue Next 3Y31.93%
Revenue Next 5Y37.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CREE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CREE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -52.28

4.3 Compensation for Growth

A more expensive valuation may be justified as CREE's earnings are expected to grow with 59.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y59.04%

0

5. Dividend

5.1 Amount

No dividends for CREE!.
Industry RankSector Rank
Dividend Yield N/A

Cree Inc

NASDAQ:CREE (10/1/2021, 7:12:25 PM)

After market: 79.78 +0.66 (+0.83%)

79.12

-1.61 (-1.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.17B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.2%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -59.72%
PM (TTM) -99.68%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.29
Quick Ratio 2.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-41.85%
Revenue growth 3Y-17.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y